Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 22 studies | 33% ± 12% | |
oligodendrocyte | 10 studies | 30% ± 8% | |
capillary endothelial cell | 7 studies | 31% ± 11% | |
endothelial cell of vascular tree | 6 studies | 31% ± 9% | |
vein endothelial cell | 5 studies | 26% ± 9% | |
epithelial cell | 4 studies | 29% ± 10% | |
basal cell | 4 studies | 23% ± 4% | |
pancreatic A cell | 3 studies | 24% ± 5% | |
endothelial cell of artery | 3 studies | 23% ± 10% | |
glomerular endothelial cell | 3 studies | 18% ± 2% | |
pericyte | 3 studies | 57% ± 27% | |
myofibroblast cell | 3 studies | 17% ± 2% | |
placental villous trophoblast | 3 studies | 51% ± 13% | |
type I pneumocyte | 3 studies | 22% ± 5% | |
type II pneumocyte | 3 studies | 27% ± 11% | |
astrocyte | 3 studies | 30% ± 9% | |
glial cell | 3 studies | 20% ± 4% | |
ciliated cell | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 13251.01 | 245 / 245 | 99% | 170.01 | 499 / 502 |
esophagus | 100% | 7899.82 | 1442 / 1445 | 98% | 78.73 | 180 / 183 |
uterus | 100% | 4919.34 | 170 / 170 | 97% | 65.77 | 446 / 459 |
intestine | 98% | 7159.88 | 944 / 966 | 98% | 71.92 | 514 / 527 |
breast | 99% | 3957.09 | 453 / 459 | 96% | 75.70 | 1078 / 1118 |
thymus | 100% | 6652.04 | 652 / 653 | 95% | 71.41 | 575 / 605 |
liver | 100% | 6582.90 | 225 / 226 | 95% | 63.57 | 387 / 406 |
bladder | 100% | 11124.52 | 21 / 21 | 95% | 86.13 | 477 / 504 |
stomach | 98% | 4093.99 | 352 / 359 | 96% | 79.69 | 274 / 286 |
pancreas | 94% | 3380.50 | 307 / 328 | 100% | 108.20 | 178 / 178 |
lung | 96% | 2750.49 | 552 / 578 | 96% | 82.98 | 1107 / 1155 |
ovary | 88% | 1918.78 | 158 / 180 | 100% | 124.85 | 430 / 430 |
kidney | 100% | 4879.99 | 89 / 89 | 84% | 79.66 | 757 / 901 |
brain | 85% | 3168.86 | 2255 / 2642 | 73% | 40.38 | 518 / 705 |
skin | 73% | 1719.53 | 1321 / 1809 | 76% | 43.67 | 360 / 472 |
adrenal gland | 62% | 1057.78 | 161 / 258 | 74% | 48.86 | 171 / 230 |
ureter | 0% | 0 | 0 / 0 | 100% | 42.14 | 1 / 1 |
adipose | 99% | 3433.61 | 1187 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 35.92 | 44 / 45 |
blood vessel | 90% | 2722.02 | 1195 / 1335 | 0% | 0 | 0 / 0 |
heart | 84% | 2002.19 | 719 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 74% | 31.15 | 59 / 80 |
lymph node | 0% | 0 | 0 / 0 | 52% | 11.87 | 15 / 29 |
spleen | 44% | 674.52 | 106 / 241 | 0% | 0 | 0 / 0 |
muscle | 6% | 88.33 | 49 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 1% | 16.23 | 12 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0048266 | Biological process | behavioral response to pain |
GO_0005604 | Cellular component | basement membrane |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005614 | Cellular component | interstitial matrix |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0050436 | Molecular function | microfibril binding |
Gene name | VWA1 |
Protein name | von Willebrand factor A domain-containing protein 1 von Willebrand factor A domain containing 1 |
Synonyms | |
Description | FUNCTION: Promotes matrix assembly (By similarity). Involved in the organization of skeletal muscles and in the formation of neuromuscular junctions (Probable). . |
Accessions | ENST00000495558.1 Q6PCB0 J3QRR0 ENST00000471398.1 ENST00000338660.5 [Q6PCB0-3] ENST00000476993.2 [Q6PCB0-1] J3QLP3 |